Kite, Arcellx announce advances in Anito-Cel Multiple Myeloma Program Ruchika Sharma12 May 2024 10:00 AM ISTRedwood City: Kite, a Gilead Company, and Arcellx, Inc. have announced several key operational updates on their partnered anitocabtagene...
Gilead's Kite, Epic Bio collaborate for development of new cancer therapies Ruchika Sharma2 Nov 2023 10:00 AM ISTUnder the terms of the agreement, Epic Bio will develop constructs for Kite-selected targets for use in CAR T-cell therapies directed to blood...
Gilead Sciences' Kite completes acquisition of Tmunity Ruchika Sharma26 Feb 2023 11:30 AM ISTSanta Monica: Kite, a Gilead Company has announced the completion of the previously announced transaction to acquire Tmunity Therapeutics, a...
GSK strikes deal to allow cheap generic versions of HIV preventive medicine Ruchika Sharma30 July 2022 12:26 PM ISTMPP offers generic manufacturers the opportunity to apply to make copycat versions of the injected drug, cabotegravir, for the 90 countries that...
Combating COVID-19: India to soon begin domestic production of Remdesivir drug Farhat Nasim14 Jun 2020 10:15 AM IST"Pharma companies have been directed to conduct Active-Post Marketing Surveillance of each case and prepare a report on the benefit or recovery of a...
Potential Megamerger: AstraZeneca approaches Gilead about possible tie-up Hina Zahid8 Jun 2020 10:00 AM ISTAstraZeneca contacted Gilead last month about a possible tie-up, the people said, asking not to be identified because the details are private.
Cipla, Hetero approach DCGI seeking waiver of Clinical Trial of Remdesivir in India: Report MD Bureau25 May 2020 4:59 PM ISTNew Delhi: With pharma companies across the country making efforts to get the first-mover advantage in bringing potential coronavirus treatments, two...
Cipla becomes 2nd firm to enter tie-up with Gilead to make remdesivir in India MD Bureau13 May 2020 9:23 AM ISTCipla will be permitted to manufacture the active pharmaceutical ingredient (API) and finished product, and market it in 127 countries including India...
Health Ministry examining Remdesivir, minister cites Confusion over price and patent MD Bureau4 May 2020 11:03 PM ISTNew Delhi: Union Health Minister Harsh Vardhan on Monday said that there is a confusion over pricing and patent of experimental anti-viral drug...
Breaking: USFDA grants Remdesivir Emergency Use Authorization in COVID-19 Treatment Hina Zahid2 May 2020 10:42 AM ISTUSA: In a major development, the U.S. Food and Drug Administration has issued an emergency use authorization for the investigational antiviral...
Gilead eyes remdesivir supplies for 1 million patients by year end MD Bureau1 May 2020 1:25 PM ISTNew York: Amid positive results from two trials of investigational antiviral drug remdesivir on hospitalised COVID-19 patients, its US-based...
Gilead, Kite and oNKo-innate collaborate to Discover Cancer Immunotherapies Focused on NK Cells Medical Dialogues Bureau25 April 2020 10:00 AM ISTAustralia - Gilead Sciences, Inc., Kite, a Gilead Company, and oNKo-innate announced the companies have entered into a three-year cancer...
